Hyloris Pharmaceuticals SA Sustainability Reports
Hyloris Pharmaceuticals S.A. is a specialty biopharmaceutical company focused on reformulating, repurposing, and optimizing existing medications to address unmet medical needs. The company leverages established regulatory pathways, primarily the FDA's 505(b)(2) pathway, to bring value-added medicines to market efficiently.
Sector: Manufacturing
Country: Belgium
Exchange: Euronext Brussels
ISIN: BE0974363955
6 reports from 2020 to 2025